Welcome to our dedicated page for BrightSpring Health Services news (Ticker: BTSG), a resource for investors and traders seeking the latest updates and insights on BrightSpring Health Services stock.
BrightSpring Health Services reports news on its home- and community-based healthcare platform for complex populations, with recurring updates on Pharmacy Solutions and Provider Services. Company announcements commonly cover financial results, guidance, service-line performance, and care delivery across pharmacy, home health care, primary care, rehabilitation and behavioral health.
BrightSpring news also includes capital actions and corporate-structure developments, including secondary offerings of common stock, share repurchases, investor presentations, and completed portfolio changes such as the sale of ResCare Community Living. These updates frame the company around its continuing pharmacy and provider health solutions business.
BrightSpring Health Services (NASDAQ: BTSG) reported second quarter 2026 net revenue of $3.873 billion, up 23.0% year over year, and gross profit of $493 million, up 31.5%. Net income from continuing operations increased to $87 million from $9 million, and Adjusted EBITDA rose 44.2% to $206 million as the company reported leverage of 2.15x following a $300 million First Lien Facility paydown and refinancing.
Pharmacy Solutions revenue grew 22% to $3.407 billion, while Provider Services revenue rose 30% to $466 million, driving total segment Adjusted EBITDA up 41% to $255 million. For full year 2026, BrightSpring raised revenue guidance to $15.1–$15.425 billion (17.0–19.5% growth) and Adjusted EBITDA guidance to $820–$845 million (32.8–36.8% growth), excluding Community Living and future acquisitions. The company expects the Amedisys and LHC branches acquisition to contribute about $35 million of 2026 Adjusted EBITDA and completed a $60 million repurchase of 1,026,465 shares alongside a secondary offering.
S&P Dow Jones Indices announced that BrightSpring Health Services (NASD: BTSG) will move from the S&P SmallCap 600 to the S&P MidCap 400, replacing Chart Industries (NYSE: GTLS), effective before the market opens on July 17, 2026. Karman Holdings (NYSE: KRMN) will join the S&P SmallCap 600, replacing BrightSpring on the same date. These index changes follow Baker Hughes (NASD: BKR) agreeing to acquire Chart Industries in a transaction expected to close on July 16, 2026, subject to final closing conditions.
BrightSpring Health Services (NASDAQ:BTSG) will release its Q2 2026 financial results on Friday, July 31, 2026, before an earnings conference call at 8:30 a.m. ET.
Investors can access a live and archived webcast and related presentation materials via the company’s investor relations website under “Events & Presentations.”
BrightSpring Health Services (NASDAQ:BTSG) appointed Dr. Nigam H. Shah as a Class III member of the Board of Directors effective June 11, 2026. He will also join the Board’s Quality and Compliance Committee.
Dr. Shah is a Stanford professor and Chief Data Scientist focused on applying AI and data science in healthcare.
BrightSpring Health Services (NASDAQ:BTSG) priced a secondary offering of 15,000,000 common shares at $58.75 per share. All shares are sold by existing stockholders, so BrightSpring will not receive proceeds. The offering is expected to close on June 5, 2026, subject to customary conditions.
BrightSpring also authorized a concurrent repurchase of 1,026,694 shares from the underwriter, drawn from the offered shares, at the same price paid by the underwriter to the selling stockholders. The share repurchase is conditioned on, and expected to close with, the offering.
BrightSpring Health Services (NASDAQ:BTSG) announced a secondary offering of 15,000,000 existing common shares by certain stockholders, including an affiliate of KKR and management. No new shares are issued and BrightSpring receives no proceeds.
The company authorized a concurrent share repurchase of up to the lesser of 10% of offered shares or $60 million, purchasing from the underwriter at the same price paid to selling stockholders. Goldman Sachs is sole book-running manager.
BrightSpring Health Services (NASDAQ: BTSG) reported Q1 2026 continuing-operations results: Revenue $3,614M (+25.6% YoY), Gross profit $482M (+42.5% YoY), Net income $74M (vs. $9M) and Adjusted EBITDA $190M (+44.8% YoY). The Company closed the Community Living divestiture (gain $31.2M) and completed a secondary offering plus a $60.0M share repurchase. Management raised full-year 2026 guidance to $14,725M–$15,225M revenue and $795M–$825M Adjusted EBITDA, and reported pro forma leverage of 2.27x as of March 31, 2026.
BrightSpring Health Services (NASDAQ: BTSG) will release its first quarter 2026 financial results on May 1, 2026 before an earnings conference call.
The Company will hold a conference call at 8:30 a.m. ET the same day; registration is required to participate. A live and archived webcast plus presentation materials will be available on the investor relations site under Events & Presentations.
BrightSpring Health Services (NASDAQ: BTSG) completed the sale of ResCare Community Living to Sevita on March 31, 2026. The divestiture, first agreed in January 2025, transfers Community Living operations to Sevita while BrightSpring refocuses on its Provider Services division: Home Health Care, Personal Care and Rehab Therapy.
The companies said the transition prioritized continuity of care, regulatory continuity, and workforce stability, and Sevita expects to expand programming and services using combined strengths.
BrightSpring Health Services (NASDAQ: BTSG) priced a previously announced underwritten secondary offering of 20,000,000 shares at $41.15 per share, expected to close on March 4, 2026. No shares are being sold by the company; selling stockholders will receive all proceeds.
The company authorized a concurrent repurchase of 1,464,807 shares from the underwriter at the offering price; the repurchase is conditioned on and expected to close simultaneously with the offering. Goldman Sachs is sole book-running manager and the offering relies on an S-3 shelf registration filed June 10, 2025.